← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3220)
- Clinical profile and initial treatment of non-small cell lung cancer: a retrospective cohort study at the Uganda Cancer Institute. (2021/12/01) ♡
- Prognostic value of the neutrophil-to-lymphocyte ratio and primary tumor location in epidermal growth factor receptor-mutated metastatic non-small cell lung cancer. (2021/12/01) ♡
- High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis. (2021/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF(V600E) mutation: a case report and review of literature. (2021/12/01) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial. (2021/12/01) ♡
- Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT). (2021/11/29) ♡
- Artemisia santolinifolia-Mediated Chemosensitization via Activation of Distinct Cell Death Modes and Suppression of STAT3/Survivin-Signaling Pathways in NSCLC. (2021/11/27) ♡
- Assessment of body composition and association with clinical outcomes in patients with lung and colorectal cancer. (2021/11/26) ♡
- Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. (2021/11/23) ♡
- Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. (2021/11/23) ♡
- 6,6'-Bieckol induces apoptosis and suppresses TGF-β-induced epithelial-mesenchymal transition in non-small lung cancer cells. (2021/11/23) ♡
- Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review. (2021/11/22) ♡
- Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer. (2021/11/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLC. (2021/11/12) ♡
- Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance. (2021/11/08) ♡
- POSTOPERATIVE ATRIAL FIBRILLATION - VIDEO-ASSISTED THORACOSCOPIC SURGERY VERSUS OPEN SURGERY. (2021/11/07) ♡
- Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis. (2021/11/05) ♡
- A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer. (2021/11/04) ♡
- Absolute Increase in the Number and Proportion of Peripheral Eosinophils Associated With Immune Checkpoint Inhibitor Treatment in Non-small Cell Lung Cancer Patients. (2021/11/03) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multimodal Prehabilitation for Lung Cancer Surgery: A Randomized Controlled Trial. (2021/11/01) ♡
- Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study. (2021/11/01) ♡
- Texture features of primary tumor on (18)F-FDG PET images in non-small cell lung cancer: The relationship between imaging and histopathological parameters. (2021/11/01) ♡
- Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective. (2021/11/01) ♡
- Increased interleukin-17A-producing γδT cells predict favorable survival in elderly patients with LUAD and LUSC. (2021/11/01) ♡
- Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors. (2021/11/01) ♡
- Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study. (2021/11/01) ♡
- Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy. (2021/11/01) ♡
- Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study. (2021/11/01) ♡
- Intraoperatory diagnosis of partial anomalous pulmonary venous return during pulmonary resection surgery in a non-small cell lung cancer patient. (2021/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib. (2021/10/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer. (2021/10/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study). (2021/10/22) ♡
- Correction Notice for "Real-World Data on Liquid Biopsy Use in Non-Small Cell Lung Cancer in the Community Setting" by Dvir et al. (2021/10/21) ♡
- Toxicity of pemetrexed during renal impairment explained-Implications for safe treatment. (2021/10/15) ♡
- Molecular genetic tests in survival factors in patients with NSCLC in the clinical practice of Kazakhstan. (2021/10/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Acupuncture against chronic postsurgical pain in non-small cell lung cancer patients: A protocol of randomized controlled trial. (2021/10/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiopulmonary bypass for resection of pancoast tumor with mediastinal extension and involvement of right bronchial branch: A case report. (2021/10/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: The debate between surgery and stereotactic body radiation therapy in treatment of early non-small cell lung cancer: A new connotation is needed for an old topic. (2021/10/05) ♡
- Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer. (2021/10/01) ♡
- Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway. (2021/10/01) ♡
- Preoperative nutritional status is associated with the prognosis for lung cancer. (2021/10/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis. (2021/10/01) ♡
- Diosgenin suppresses COX-2 and mPGES-1 via GR and improves LPS-induced liver injury in mouse. (2021/10/01) ♡
- Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events. (2021/10/01) ♡
- Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based Chemotherapy. (2021/10/01) ♡
- Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer. (2021/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sulforaphane overcomes T790M-mediated gefitinib resistance in vitro through epithelial-mesenchymal transition. (2021/10/01) ♡
- Long Non-coding RNA snaR Promotes Proliferation in EGFR Wild Type Non-Small Cell Lung Cancer Cells. (2021/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Microbiota in Lung Cancer: Where Do We Stand? (2021/09/27) ♡
- Differences between lung adenocarcinoma and squamous cell carcinoma in histological distribution of residual tumor after induction chemoradiotherapy. (2021/09/27) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.